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Accepted 12 December 1995When neutrophil leukocytes are stimulated by
chemotactic factors or by substratum contact, they change
their shape. Shape changes are a prerequisite for cellular
migration and typically involve the extrusion of thin, veil-
like lamellipods and the development of morphological
polarity. Stimulation also leads to changes in the neutrophil
content of filamentous actin (F-actin), which is the major
cytoskeletal component. Suspensions of human neutrophils
stimulated with chemoattractants exhibit sinusoidal light-
scattering oscillations with a period of approximately 8 s at
37 °C. These oscillations arise from periodic fluctuations in
the cell body size caused by lamellipod extension and
retraction cycles. The light-scattering oscillations are
paralleled by corresponding oscillations in F-actin content.
This raises the interesting possibility that cyclic actin
polymerization constitutes the driving force for shape
oscillations of suspended neutrophils. Similar periodic
shape changes are present in neutrophils crawling on a
surface, suggesting that shape oscillations are important
for neutrophil motion. This review summarizes our present
knowledge about shape oscillations in suspended and
crawling neutrophils and discusses a possible role for these
oscillations in neutrophil motility.
Key words: polymorphonuclear leukocyte, locomotion, shape change,
lamellipod, pseudopod, cytoskeleton, actin, turbidimetry.
SummaryMotile cells change their shape and crawl in response to
external stimuli by the extrusion and retraction of lamellipods,
a process that requires rearrangement of cytoskeletal actin
(Stossel, 1993). Cycles of small-scale shape changes then
result in net cell translocation (Hartman et al. 1994). When
viewed at sufficiently high temporal resolution, cyclic
periodicities are found in the cellular shape changes of many
crawling cell types, including neutrophil leukocytes (Hartman
et al. 1994), Dictyostelium discoideum (Killich et al. 1993),
Physarum polycephalum and Amoeba proteus (Satoh et al.
1985). We have been interested in the shape-change
periodicities of suspended and attached human neutrophils.
These phagocytic cells constitute the first-line defense system
of the vertebrate organism against microbes. They migrate up
chemotactic gradients to infection sources, where they kill
invading microorganisms by the release of powerful oxygen
radicals (‘respiratory burst’) and digestive enzymes. Here, we
discuss our recent results supporting the hypothesis that shape
oscillations are a fundamental feature of neutrophil migration.
Introduction*Published posthumously.
†Author for correspondence.Suspended neutrophils
Suspended resting neutrophils are spherical, with a volume
of 300 mm3 (Ting-Beall et al. 1993), corresponding to a
diameter of 8.3 mm, and are smooth without membrane
ruffling (Wilkinson and Haston, 1988; Watts et al. 1991).
Upon stimulation with chemotactic agonists, these cells
undergo a shape change which can be assessed both
microscopically and turbidimetrically (Yuli and Snyderman,
1984; Wymann et al. 1987). The cellular protrusions formed
after stimulation can be morphologically separated into
lamellipods and pseudopods (Luna and Hitt, 1992; Stossel,
1994). Lamellipods (also termed ‘membrane ruffles’)
develop early after stimulation, are thin, clear, veil-like and
extruded across large areas of the cell surface, while the cell
body per se remains spherical (Wymann et al. 1987; Watts
et al. 1991). Pseudopods are produced later and are of
moderate width with respect to the dimensions of the cell;
they give the activated neutrophil a polarized morphology
(Watts et al. 1991) and are similar to the pseudopod extruded
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Table 1. Agonists provoking shape oscillations in human neutrophils
Agonist Origin Reference
Peptides
N-Formyl-Met-Leu-Phe Bacteria Wymann et al. (1987, 1989, 1990); Ehrengruber
et al. (1995b)
Complement fragment 5a Complement system Wymann et al. (1987); Ehrengruber et al. (1995b)
Interleukin-8 Macrophages and endothelial Ehrengruber et al. (1995b)
cells
Neutrophil-activating peptide-2 Platelets M. U. Ehrengruber (unpublished results)
Lipids
Leukotriene B4 Phagocytes Wymann et al. (1987); Omann et al. (1989)
Platelet-activating factor Leukocytes and tissue cells Wymann et al. (1987); Omann et al. (1989)
Certain agonists known to induce scattering-detected shape changes, i.e. GROa/MGSA (Geiser et al. 1993) and complement fragment 3a
(Ehrengruber et al. 1994b), were unable to provoke shape oscillations (M. U. Ehrengruber and D. A. Deranleau, unpublished results).towards higher chemoattractant concentrations in cells
crawling over a substratum (Devreotes and Zigmond, 1988).
Thus, we can think of shape change as consisting of at least
two superimposed events: (i) the development of a dominant
pseudopod, resulting in a polar shape; and (ii) the formation
of smaller, veil-like membrane ruffles superimposed on the
dominant pseudopod.
The cellular scattering extinction coefficient, which we
determined as 65.8±6.9 for resting neutrophils at 37 °C (mean
± S.D. at 632.8 nm, N=332; M. U. Ehrengruber and D. A.
Deranleau, unpublished results), is a sensitive measure of
cellular size and/or shape (Latimer, 1979; Deranleau, 1987).
Chemoattractants such as N-formyl-Met-Leu-Phe (fMLP)
decrease neutrophil extinction and light scattering by inducing
lamellipod formation (Yuli and Snyderman, 1984; Sklar et al.
1984; Wymann et al. 1987). In synchronized cell populations,Fig. 1. Neutrophil shape oscillations at 25 and 37 °C. Relative changes
in 90 ° scattering (top) and extinction (bottom) of cells pretreated with
1 mmol l21 17-hydroxywortmannin (HWT) (for 10 min) and
stimulated with 10 nmol l21 N-formyl-Met-Leu-Phe (fMLP, arrow)
are shown. The extinction coefficient of resting human neutrophils at
37 °C is 65.8±6.9 (mean ± S.D. at 632.8 nm, N=332).the agonist-induced scattering changes exhibit sinusoidal,
temperature-dependent oscillations (Fig. 1) with a period of
8.4±0.8 s at 37 °C (Wymann et al. 1987; Omann et al. 1989;
Ehrengruber et al. 1995b). They can be provoked by both
peptide and lipid agonists (Table 1) and show the same
activation energy as oscillations in neutrophil filamentous
actin (F-actin) content (Omann et al. 1989; Ehrengruber et al.
1995b). While clearly oscillating responses are rarely
observed in suspensions of resting neutrophils, they are
routinely ‘enabled’ by pretreatment with wortmannin, 17-
hydroxywortmannin (HWT; phosphatidylinositol 3-kinase
inhibitors), with phorbol 12-myristate 13-acetate and by
prestimulation with an agonist (Wymann et al. 1987, 1989;
Ehrengruber et al. 1995b). We have demonstrated that the
oscillation frequencies increase with increasing prestimulation
of the cells (Ehrengruber et al. 1995b).
Scattering oscillations are paralleled by inverse oscillations
in F-actin content (Omann et al. 1989; Wymann et al. 1990).
Scattering theory suggests that the optical oscillations result
from cyclic alterations in cell body size due to the extension
and retraction of comparatively weakly scattering lamellipods
(Deranleau, 1988; Wymann et al. 1990), a prediction which we
recently verified (Ehrengruber et al. 1994a). As motility of
cells moving on surfaces is characterized by extrusion and
remodeling of lamellipods, shape oscillations of suspended
neutrophils could reflect crawling motions of activated cells
(Wymann et al. 1990). Newly formed lamellipods typically
contain an F-actin network (Fechheimer and Zigmond, 1983;
Zigmond, 1993) which may be more labile than that in the cell
body (Cassimeris et al. 1990). The presence of more than one
pool of F-actin has been documented operationally and
biochemically (Watts and Howard, 1992, 1993, 1994),
although morphological localization has not been
accomplished.
Crawling neutrophils
Neutrophil migration consists of three components
(Bignold, 1992): (i) the cellular driving motor; (ii) the
transmission of driving forces to the cell periphery; and (iii)
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the traction of the cell periphery on the substratum, where
reversible adhesive interactions between lamellipods and the
substratum occur. Reversible adhesive interactions formed at
one stage must be reversed at a later stage, when the cell body
has followed the leading lamellipod (Felder and Kam, 1994).
In the absence of a chemotactic gradient, neutrophils extend
pseudopods in random directions, and the cells show
undirected motility with a constant frequency of cellular turns.
Chemoattractants do not alter the turning frequency of the cell,
but dramatically decrease the angle between the direction of
pseudopod extension and the chemotactic gradient, rapidly
resulting in accurate orientation of the cell along the gradient
(Zigmond et al. 1981; Devreotes and Zigmond, 1988; de
Boisfleury-Chevance et al. 1989). As little as a 2 % change in
concentration over 10 mm of cell length can be detected by a
neutrophil. This orientation accuracy of the neutrophil is
established by a mechanism that senses the change in receptor
occupancy which occurs upon displacement along the cell
(Devreotes and Zigmond, 1988).
Measurements made on spontaneously migrating single
neutrophils show that they exhibit shape oscillations with
periodicity components at 8 and 20–30 s at 37 °C. No
pretreatment is required to enable oscillations and they occur
in about 75 % of migrating cells (Hartman et al. 1994). When
neutrophils migrate in a chemotactic gradient, their cell
velocity oscillates (between 10 and 30 mm min21) with a
period of 50–55 s. During their periodic bursts of speed,
neutrophils are more flattened, possess an extended leading
lamella forming contacts with the substratum and, with a slight
phase lag, rapidly move their cell body over the immobile
contacts (Felder and Kam, 1994). The same period was found
for the characteristic time of the ‘internal clock’ between
successive directional changes (de Boisfleury-Chevance et al.
1989). An elegant real-time study (Guilford et al. 1995)
demonstrated that the force production of locomoting
macrophages is periodic (period of 33–100 s for unstimulated
cells, 50–200 s after addition of fMLP) and correlates with
extension of the leading lamella. This suggests that mechanical
oscillations are present in cells other than neutrophils. Guilford
et al. (1995) also showed that force generation is not well
correlated to cell ruffling, and concluded that ruffling and
locomotion are controlled differentially and have distinct
origins.
Signal transduction
The signal transduction cascade that controls shape change
and motility is not clearly understood, though the number of
candidate molecules seems to increase daily. Regulation of
actin polymerization and cross-linking, ion channels and
adhesion proteins are all involved. We attempted to investigate
some possible mechanisms by using pharmacological
manipulations of signal transduction pathways. While the
specificity of such approaches is always in question, these
studies point to directions for further detailed biochemical
studies.There are several treatments which block the neutrophil
shape change and, therefore, prevent shape oscillations. We
have listed various agents from our own experience or from
the literature which were tested on the fMLP-induced shape
change, on oscillations or on both (Table 2). For reference, we
have included their effect on the respiratory burst as well.
Several conclusions can be drawn from the data. First, shape
change and oscillations depend on agonist–receptor binding
and heterotrimeric G-proteins, as well as on the presence of an
intact cytoskeleton. Second, tyrosine phosphorylation seems to
be important, though no separate effect on oscillations could
be seen. All agents to date which inhibit shape change also
block oscillations. Third, as cell volume and shape change are
regulated partially by fluid and Na+ transport (Rosengren et al.
1994), Na+ homeostasis could be involved in the oscillations.
While manipulation of Na+ transport had no effect on shape
change or oscillations, replacement of all external Na+ with
choline inhibited the initial phase of the fMLP-induced shape
change by approximately 50 % and almost completely blocked
the oscillations. Furthermore, these manipulations had no
effect on the initial fMLP-induced change in F-actin content
(M. U. Ehrengruber, D. A. Deranleau and T. D. Coates,
unpublished observations). This suggests that the initial shape
change is partially due to actin-independent volume changes.
The only treatment that selectively affects oscillations
without blocking the shape change per se was internal ATP
depletion (Table 2). Addition of fMLP to ATP-depleted
neutrophils induced a non-oscillating shape change, which did
not return to baseline (up to 30 min), whereas agonist-induced
transients reversed to resting levels after approximately 3 min
in control cells. This persistent shape change was reversed by
addition of receptor antagonist. Subsequent addition of
another agonist (interleukin-8), acting through a different
receptor, stimulated a second sustained shape change (M. U.
Ehrengruber and D. A. Deranleau, unpublished results). These
data imply that ATP is not required for actin polymerization
but is required for remodeling actin. Furthermore, the presence
of an agonist is required to maintain a shape change. Our
conclusion that ATP is not required for actin polymerization
agrees with the finding that inhibition of tyrosine phosphatases
alone, which do not depend on ATP, elicits neutrophil shape
change, whereas shape change is prevented by tyrosine kinase
inhibitors (Bennet et al. 1993). In addition, we found that
inhibition of tyrosine phosphatases prevents subsequent fMLP-
induced shape changes and oscillations (Table 2). Thus, one
can speculate as to a possible role for tyrosine
kinase/phosphatase balance in the control of neutrophil shape.
Parallel sinusoidal oscillations in cellular shape and
respiratory burst activity occur in stimulated neutrophils,
suggesting the existence of a common regulator in their signal
transduction pathways (Wymann et al. 1989). However, the
fact that internal Ca2+ depletion, protein kinase C inhibition
and HWT pretreatment block the respiratory burst but not
shape change suggests that the respective signal transduction
pathways diverge at an early stage (Baggiolini and Kernen,
1992).
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Table 2. Effect of various treatments on fMLP-induced neutrophil respiratory burst, shape change and oscillations
Block of
respiratory Block of shape
Treatment Site of action burst Change Oscillations Reference1
N-t-Boc-Met-Leu-Phe Receptor antagonist Yes Yes Yes Wymann et al. (1989)
Bordetella pertussis toxin Heterotrimeric G-proteins Yes Yes Yes Wymann et al. (1989)
(Gi type)
Cytochalasin B (10 mmol l- 1) F-actin No2 Yes Yes
Chlorpromazine (100 mmol l- 1) Microtubules, calmodulin Yes Yes
Staurosporine Ca2+-dependent protein kinases Yes No No Wymann et al. (1989)
Internal Ca2+ depletion Ca2+-dependent protein kinases Yes No No Wymann et al. (1989)
Erbstatin, methyl-2,5-dihydroxy- Tyrosine kinases Yes* Yes† Yes Naccache et al. (1990)*; 
cinnamate (20–35 mmol l- 1) Bennet et al. (1993)†
Genistein (100 mmol l- 1) Tyrosine kinases Yes* Yes Yes Azuma et al. (1993)*
Calyculin A (20 mmol l- 1)3 Serine/threonine phosphatases No* No No Djerdjouri et al. (1995)*
(type 1 and 2A)
Sodium orthovanadate (1 mmol l- 1) Tyrosine phosphatases No* Yes Yes Mayer and Spitzer (1994)*; 
Lloyds and Hallet (1994)*
Manoalide (0.2 mmol l- 1)4 Phospholipases A2 Yes* No No Mayer and Spitzer (1994)*
Exoenzyme C3 Rho proteins No No5 Ehrengruber et al. (1995a)
17-Hydroxywortmannin Phosphatidylinositol 3-kinases Yes No No Wymann et al. (1989)
Monensin (10 mmol l- 1) Na+/H+ ionophore No6 No
Amiloride (1 mmol l- 1), dimethyl- Na+/H+ antiporter No No
amiloride (100–500 mmol l- 1)7
Ouabain (1 mmol l- 1) Na+/K+ antiporter No No
pH 4.9 (90 min) No No
Removal of external Na+ Yes8 Yes
2-Deoxy-D-glucose (5 mmol l- 1) ATP depletion No9 Yes
1M. U. Ehrengruber and D. A. Deranleau, unpublished results if not otherwise indicated.
2Enhancement.
3Concentration high enough to induce shape change by itself (Kreienbuhl et al. 1992).
4Concentration high enough to inhibit fMLP-induced degranulation (Barnette et al. 1994).
5Enhancement.
6Inhibition at higher concentrations (50–100 mmol l- 1).
7Concentration high enough to block fMLP-dependent volume changes and chemotaxis (Rosengren et al. 1994).
8Partial inhibition.
9Shape change sustains at elevated level, reverses upon antagonist addition, and can be provoked again with a different agonist.Biophysical description of the oscillations
The light-scattering changes of resting neutrophils stimulated
once with an agonist (Yuli and Snyderman, 1984; Sklar et al.
1984; Ehrengruber et al. 1995b) follow the kinetics of a critically
damped oscillator. Enabling of oscillations could therefore
consist of removing a damping effect (Fig. 2). From a biophysical
viewpoint, the oscillations appear to be damped and
superimposed on a lower-frequency transient change in shape
which lasts 40–60s (Wymann et al. 1990). Both the high- and
low-frequency shape changes have been closely linked to
polymerization and depolymerization of actin (Yuli and
Snyderman, 1984; Omann et al. 1989; Wymann et al. 1990;
Watts et al. 1991; Coates et al. 1992). Therefore, the biochemical
reactions which account for the low-frequency transient, the
oscillations and the damping probably target proteins involved in
controlling the structure of the cytoskeleton. Water and Na+
transport may also be important (Rosengren et al. 1994).
The nature of the damping component in the neutrophil signaltransduction has yet to be resolved. The fact that fMLP-induced
light-scattering changes appear to be critically damped in
neutrophils that have been both ATP-depleted and HWT-
pretreated (M. U. Ehrengruber and D. A. Deranleau,
unpublished results) indicates that internal ATP is involved in
the damping of the oscillations. Furthermore, because
oscillations are enabled or enhanced by certain treatments which
inhibit phosphatidylinositol 3-kinase activity, i.e. pretreatment
with HWT or wortmannin (Wymann et al. 1987; Ehrengruber
et al. 1995b), prestimulation with an agonist (Ehrengruber et al.
1995b), and Rho inhibition (Ehrengruber et al. 1995a), this
enzyme activity may be involved in the regulation of the
oscillations. However, as the oscillation frequency can be
modulated even under complete phosphatidylinositol 3-kinase
inhibition (Ehrengruber et al. 1995a,b), factors other than or in
addition to this enzyme must be involved in the regulation.
While there are several candidate pathways for control of the
oscillations, the major mechanisms remain unknown.
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Fig. 2. Hypothetical role of shape oscillations in neutrophil migration.
Two real-time tracings of 90 ° scattering changes stimulated with
10 nmol l21 fMLP (at 37 °C) are included. Resting neutrophils are
spherical (A) and develop lamellipods (‘membrane ruffles’) within
seconds after their first encounter with a chemoattractant or possibly
a substratum (B). The neutrophil shape polarizes through the
formation of a dominant pseudopod (C) as total F-actin content and
light-scattering return towards baseline levels (Wymann et al. 1987;
Watts et al. 1991; Coates et al. 1992). In suspension, the
chemoattractant or pharmacological agents enable 8 s period
oscillations, which are then provoked when the cell encounters the
triggering stimulus (D). Exactly what provides the natural enabling
event is unclear, but surface contact would be a reasonable first
candidate. A chemoattractant gradient might be able of enabling and
provoking oscillations in a manner analogous to repeated stimuli
(Ehrengruber et al. 1995b). The cell then moves forward from D to
E with the persistence time of 30–60 s, similar to the length of time
that it takes the train of oscillations to die out in suspended
neutrophils. As one cycle of the ‘internal clock’ (de Boisfleury-
Chevance et al. 1989) is completed, the neutrophil can then change
its direction of movement (E) before another train of oscillations
propels it on another straight-line segment (from E to F) of its path.
Repetitions of this process lead the neutrophil to its final destination.Correlation with neutrophil migration
Recurring lamellipod protrusion and retraction, driven by
corresponding actin polymerization–depolymerization cycles
(Wymann et al. 1990), are an integral feature of the mechanism
responsible for the amoeboid-like crawling motions typical of
neutrophils seeking bacterial targets (Hartman et al. 1994;
Felder and Kam, 1994). During their walk, neutrophils move
in approximately straight paths separated, at certain time
intervals, by discrete changes in direction. At 37 °C, a mean
transit time of 50–55 s is the characteristic time between
successive directional changes (de Boisfleury-Chevance et al.
1989). This time corresponds nicely to the 40–60 s decay time
(envelope) of shape oscillations we see in suspension (Fig. 1;
Wymann et al. 1987, 1990; Omann et al. 1989; Ehrengruber
et al. 1995b). Interestingly, our studies on individual migrating
neutrophils clearly detect shape oscillations with a period of
8–10 s, which may be identical with the lamellipod formation-
dependent light-scattering oscillations of suspended
neutrophils (Hartman et al. 1994). We hypothesize that these
high-frequency shape oscillations reflect the fundamental
cyclic driving force for neutrophil migration. If such a motor
were directly translated into movement, then the neutrophil
displacement magnitudes or turn angles would be cyclic
(Hartman et al. 1994). Such periodic neutrophil motion has
been demonstrated recently (Hartman et al. 1994; Felder and
Kam, 1994). Our current understanding of the involvement of
shape oscillations in neutrophil migration is summarized in
Fig. 2.
These data suggest that the fundamental neutrophil motor
may be under tonic inhibition. Addition of agonist removes the
inhibition and enables biochemical oscillations which lead to
the detected cycles in shape change (Ehrengruber et al. 1995b).
The exponential decay of oscillations seen in suspension after
agonist addition (Wymann et al. 1987, 1990; Omann et al.
1989; Ehrengruber et al. 1995b) and the bursts of persistent
(straight-line) motion which die out after 30–60 s on surfaces
(Hartman et al. 1994; Felder and Kam, 1994) may be due to
the same processes. The relative contributions of the high-
frequency and low-frequency shape-change components on
directed movement are not known. In fact, we do not know for
certain that the oscillations seen in suspension are due to the
same process that occurs on a surface. Furthermore, motility
observed on a two-dimensional surface may not be the same
as in a three-dimensional tissue. It is clear that lamellipod
formation and polar shape change occur perfectly well in
suspension without the need for a surface or a stimulus gradient
(Yuli and Snyderman, 1984; Watts et al. 1991; Coates et al.
1992). Thus, both aspects of neutrophil shape change are
intrinsic properties of the cell. Could it be that surface contact
is the natural biochemical event that enables oscillations?
Similarly, encounter with a chemoattractant gradient could act
to enable mechanical oscillations, as is the case for repetitive
stimulation with peptide agonists in suspension (Ehrengruber
et al. 1995b). Certainly, the specific adhesive interactions of
the neutrophil with a surface serve to modulate biochemical
events within the cell. Carefully regulated adhesive interactionwith the substratum could convert the shape changes generated
within the cell into directed movement. This model, which
portrays neutrophil migration as repeating cycles of small- and
large-scale shape change, opens the door to many predictions
about net neutrophil displacement that could be derived from
746 M. U. EHRENGRUBER, D. A. DERANLEAU AND T. D. COATESexperimental measurements of the amplitude and directions of
the oscillations in shape.
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